STOP-AKI (2018) — Trial Summary

STOP-AKI (2018): Evaluated the efficacy of recombinant alkaline phosphatase in patients with sepsis-associated acute kidney injury.

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.